The Call for Applications for the 2021 OBIO Capital Access Advisory Program (CAAP®) is now open. Deadline for applications is Sunday, February 28th at 11:59 PM EST.
OBIO CAAP is a competitive, 10-month structured program (April-Feb) for health science companies seeking to raise post-seed financing in the 2021 to 2022 timeframe, culminating at the 2022 OBIO Investment Summit where CAAP companies will present to and meet with global investors. Companies presenting at the Summit have raised over $390M.
Information session: Wednesday, February 17h from 12 to 1 PM EST (Register Here)
Application deadline: Sunday, February 28th at 11:59 PM EST. (Click Here to Apply)